IP Library Granted Patent US 10,760,058
Granted Patent B2
US 10,760,058 · App. 15/590,475 · Granted Sep 1, 2020

Acellular biologic composition and method of manufacture

Inventors: Timothy Ganey (Tampa, FL); Wendy W. Weston (Miami, FL); Miguel Quevedo (Miami, FL); Stuart Oglesby (Miami, FL); Gaetan Jean-Robert Delcroix (Miami, FL); Paul C. Schiller (Miami Beach, FL); Gianluca D'Ippolito (North Miami Beach, FL)
Assignee: Vivex Biologics Group, Inc.
C12N5/0669A01N1/0221A01N1/0284A61K35/28A61K35/32A61L27/3604A61L27/365A61L27/3608A61L27/3691A61L27/3834A61L27/446A61L27/50A61L27/54A61L27/58A61K2035/124A61K2300/00A61L2430/00A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,760,058
App. No.
15/590,475
Granted
Sep 1, 2020
Kind
B2
Abstract

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.

Claims (18)

1. A method of preparing a biological composition for use comprises the steps of:

collecting, recovering and processing bone marrow from a cadaver donor;

mechanically separating by spinning or tumbling cellular and non-cellular components of bone marrow from cadaverous bone using a plurality of cycles, wherein the first cycle has a decanted fluid of unwanted cells and debris which is discarded, thereafter subsequent cycles are performed, each subsequent cycle creating a decanted fluid which is retained containing the cellular and non-cellular components, the retained decanted fluid is combined in a collection jar prior to centrifugation and passed through a blood filter to remove any bone or spicules or clumps from the cells and the non-whole cell components;

concentrating the separated cellular and non-cellular components by centrifugation;

separation of cellular and non-cellular components by density gradient centrifugation;

collecting non-cellular fractions or non-cellular components or combinations in a fluid above an interface containing whole cells;

washing the non-cellular fractions or non-cellular components or combinations thereof to create a mixture;

quantifying non-whole cell fraction from the fluid above the interface has a concentration exceeding zero;

suspending the mixture in a polyampholyte cryoprotectant;

freezing the mixture.

2. The method of preparing the biological composition for use of claim 1 further comprises the steps of:

thawing the mixture; and

implanting the thawed mixture with a bone blend being intermixed by packing, injection or any other suitable means into a patient.

3. The method of preparing the biological composition for use of claim 2 wherein the step of thawing the mixture occurs at a temperature of 37 degrees C. for 2 to 3 minutes in a warm water bath.

4. The method of preparing the biological composition for use of claim 2 further comprises the step of:

diluting the thawed mixture in saline without spinning.

5. The method of preparing the biological composition for use of claim 3 further comprises the step of:

diluting the thawed mixture in saline without spinning.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2020
From: WESTON, WENDY W.; DELCROIX, GAETAN JEAN-ROBERT; D'IPPOLITO, GIANLUCA; GANEY, TIMOTHY; QUEVEDO, MIGUEL; OGLESBY, STUART; SCHILLER, PAUL C.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 051967/0326 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
SECURITY INTEREST Recorded Apr 30, 2018
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 045671/0435 →
Continuity (4)
Division 14682523 · Apr 9, 2015
Provisional Application 62129351 · Mar 6, 2015
Provisional Application 62129337 · Mar 6, 2015
Related Publication 20170240862A1 · Aug 24, 2017